Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy

被引:1
|
作者
Dong, Lei [1 ,2 ]
Zhu, Yini [3 ]
Zhang, Haoge [4 ]
Gao, Lin [4 ]
Zhang, Zhiqi [4 ]
Xu, Xiaoxuan [4 ]
Ying, Leqian [1 ,2 ]
Zhang, Lu [1 ,2 ]
Li, Yue [5 ]
Yun, Zhengcheng [1 ,2 ]
Zhu, Danqi [4 ]
Han, Chang [4 ]
Xu, Tingting [1 ,2 ]
Yang, Hui [6 ]
Ju, Shenghong [4 ]
Chen, Xiaoyuan [4 ,7 ,8 ,9 ,10 ,11 ,12 ,13 ,14 ]
Zhang, Haijun [1 ,2 ]
Xie, Jinbing [4 ]
机构
[1] Southeast Univ, Zhongda Hosp, Med Sch, Nurturing Ctr Jiangsu Prov,State Lab AI Imaging &, 87 Dingjiaqiao, Nanjing 210009, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Med Sch, Dept Oncol, 87 Dingjiaqiao, Nanjing 210009, Peoples R China
[3] Southeast Univ, Med Sch, Dept Microbiol & Immunol, Nanjing 210009, Jiangsu, Peoples R China
[4] Southeast Univ, Zhongda Hosp, Basic Med Res & Innovat Ctr, Med Sch,Dept Radiol,Minist Educ,State Key Lab Digi, Nanjing, Peoples R China
[5] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China
[6] Southeast Univ, Med Sch, Dept Biochem & Mol Biol, Nanjing, Peoples R China
[7] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Diagnost Radiol, Singapore 119074, Singapore
[8] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119074, Singapore
[9] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Chem & Biomol Engn, Singapore 119074, Singapore
[10] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biomed Engn, Singapore 119074, Singapore
[11] Natl Univ Singapore, Coll Design & Engn, Singapore 119074, Singapore
[12] Natl Univ Singapore, NUS Ctr Nanomed, Yong Loo Lin Sch Med, Nanomed Translat Res Program, Singapore 117597, Singapore
[13] Natl Univ Singapore, Clin Imaging Res Ctr, Ctr Translat Med, Yong Loo Lin Sch Med, Singapore 117599, Singapore
[14] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore
基金
中国国家自然科学基金;
关键词
CXCL10; glioblastoma; IL-2; immune checkpoint inhibitors; immunosuppressive microenvironment; low-frequency focused ultrasound; T-cell exhaustion; THERAPY;
D O I
10.1002/adma.202407235
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Improving clinical immunotherapy for glioblastoma (GBM) relies on addressing the immunosuppressive tumor microenvironment (TME). Enhancing CD8(+) T cell infiltration and preventing its exhaustion holds promise for effective GBM immunotherapy. Here, a low-intensity focused ultrasound (LIFU)-guided sequential delivery strategy is developed to enhance CD8(+) T cells infiltration and activity in the GBM region. The sequential delivery of CXC chemokine ligand 10 (CXCL10) to recruit CD8(+) T cells and interleukin-2 (IL-2) to reduce their exhaustion is termed an "open-source throttling" strategy. Consequently, up to 3.39-fold of CD8(+) T cells are observed with LIFU-guided sequential delivery of CXCL10, IL-2, and anti-programmed cell death 1 ligand 1 (aPD-L1), compared to the free aPD-L1 group. The immune checkpoint inhibitors (ICIs) therapeutic efficacy is substantially enhanced by the reversed immunosuppressive TME due to the expansion of CD8(+) T cells, resulting in the elimination of tumor, prolonged survival time, and long-term immune memory establishment in orthotopic GBM mice. Overall, LIFU-guided sequential cytokine and ICIs delivery offers an "open-source throttling" strategy of CD8(+) T cells, which may present a promising strategy for brain-tumor immunotherapy.
引用
收藏
页数:15
相关论文
empty
未找到相关数据